Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An Epstein-Barr virus-associated malignant lymphoproliferative disorder, developing in a context of long-standing or slow-growing, chronically inflamed lesions, such as chronic pyothorax, metallic implants in bones and joints, chronic osteomyelitis, chronic venous ulcer, or, rarely granulomatous inflammation. The tumor is usually primarily localized, with no involvement of other organs.
Biomarker and diagnostic research for diffuse large B-cell lymphoma with chronic inflammation has been reported in the published literature.
No clinical trials have been registered for diffuse large B-cell lymphoma with chronic inflammation.
32 publications have been identified in PubMed for diffuse large B-cell lymphoma with chronic inflammation. Research spans Case Report / Case Series (34%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 34% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:02 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
8 |
25% |
Laboratory research | 6 | 19% |
Testing and diagnosis research | 3 | 9% |
Disease patterns and progression | 2 | 6% |
Clinical study results | 1 | 3% |
New treatment approaches | 1 | 3% |
Czernilofsky F (2026). [PMID: 41882179](https://pubmed.ncbi.nlm.nih.gov/41882179/). *Nat Cancer*. [Basic Science / Preclinical]
Živković E (2026). [PMID: 42041535](https://pubmed.ncbi.nlm.nih.gov/42041535/). *Cells*. [Basic Science / Preclinical]
Vets J (2026). [PMID: 41934612](https://pubmed.ncbi.nlm.nih.gov/41934612/). *Expert Rev Hematol*. [Review / Meta-Analysis]
Maerten T (2026). [PMID: 41659022](https://pubmed.ncbi.nlm.nih.gov/41659022/). *Case Rep Hematol*. [Epidemiology / Natural History]
Han Z (2026). [PMID: 41819011](https://pubmed.ncbi.nlm.nih.gov/41819011/). *Curr Res Transl Med*. [Epidemiology / Natural History]
Matwiejuk M (2026). [PMID: 42042898](https://pubmed.ncbi.nlm.nih.gov/42042898/). *Metabolites*. [Review / Meta-Analysis]
Sherief DE (2026). [PMID: 41608342](https://pubmed.ncbi.nlm.nih.gov/41608342/). *World J Clin Oncol*. [Diagnostic / Biomarker]
Fujita A (2026). [PMID: 41990144](https://pubmed.ncbi.nlm.nih.gov/41990144/). *JBJS Case Connect*. [Case Report / Case Series]
Abdurrahman MY (2026). [PMID: 42181408](https://pubmed.ncbi.nlm.nih.gov/42181408/). *Cureus*. [Case Report / Case Series]
Pelzl RJ (2025). [PMID: 40359478](https://pubmed.ncbi.nlm.nih.gov/40359478/). *Blood*. [Basic Science / Preclinical]
AI-curated news mentioning diffuse large B-cell lymphoma with chronic inflammation
Updated Aug 25, 2026
A new study highlights the diagnostic challenges associated with primary colonic diffuse large B-cell lymphoma. The findings emphasize the need for improved diagnostic criteria to enhance detection and treatment outcomes.